# Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis

> **NCT07668895** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 126 (estimated)

## Conditions studied

- Sarcoidosis, Pulmonary

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Compound betamethasone

## Key facts

- **NCT ID:** NCT07668895
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668895, "Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*